Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 millionPUBT·Aug 21 at 05:07 AM01513+0.30%000513+1.42%
Livzon Pharma FY26 H1 net profit drops 27.23% to RMB 932.2 million; revenue falls 20.28% to RMB 5 billionPUBT·Aug 21 at 05:03 AM01513+0.30%000513+1.42%
Biotech Breakthroughs and Data Center Hardware Pace Resilient Pockets in HK EquitiesGlobal Report·Jul 7 at 05:38 AM01513+0.30%01833+0.15%
